Company confirms 12 patients enrolled in Phase 2 THIO-101 to date as expansion trial adds new countries Posters for Phase 2 and Phase 3 clinical ...

Internal records reveal that for years Penn State’s clinical cancer research was mired in deep-rooted and potentially ...

The latest update is out from Purple Biotech ( (PPBT) ).

The Brisbane Cancer Conference is a premier oncology meeting that brings together leading international researchers, clinicians and industry experts working in the fields of translational oncology, ...

Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals ...

Whether your family is affected by Alzheimer's or you simply want to learn more about the disease, this conference in Boca ...

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

Black and Hispanic individuals with obesity appear underrepresented in GLP-1 weight loss trials, compared with the overall ...

First presentation of U.S. IDE clinical data shows statistically significant improvements in pain and function at 24 months compared with fusion surgery BEVERLY HILLS, CA / ACCESS Newswire / November ...

CAMBRIDGE, Mass., Nov. 7, 2025 /PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering precision immunotherapies for oncology and inflammation & immunology (I&I), ...

(MENAFN- GlobeNewsWire - Nasdaq) – Trial met primary endpoint, with statistically significant reductions in liver fat observed in all HU6 treatment groups – – In addition to robust liver-centric ...

WINSTON-SALEM, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cell therapy company focused on CKD, today presented ...